Cargando…
Multiple Sclerosis : Clinician's Guide to Diagnosis and Treatment.
Multiple Sclerosis (MS) is an inflammatory, often progressive, and potentially disabling disease of the central nervous system. Onset of disease is usually between the ages of 15 and 50, with the incidence nearly twice as high in women. While the cause of MS is still unknown, the predominant theory...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford :
Oxford University Press, USA,
2013.
|
| Edición: | 2nd ed. |
| Colección: | Oxford American neurology library.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; Contents; Acknowledgment; Introduction; 1. A Brief History of Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; 2. Factors Involved in Causing Multiple Sclerosis; Epidemiology; Causes of MS; Immunology; 3. The Patterns and Pathophysiology of MS; Patterns of MS; Pathophysiology of MS; 4. Imaging of the Central Nervous System in Multiple Sclerosis; Standard X-Ray Imaging of the Skull and Spinal Column; Computed Tomography (CT) Imaging of the CNS; Magnetic Resonance Imaging; 5. Making a Diagnosis of Multiple Sclerosis; Patterns of Disease Presentation; Demographics.
- Genetics of MSInitial Clinical Symptoms in Persons with Relapsing-Remitting MS; Initial Clinical Symptoms of Primary-Progressive MS; Presenting Signs in Multiple Sclerosis; Magnetic Resonance Imaging; Evoked Responses; Cerebrospinal Fluid Analysis; Ruling Out MS "Look-alikes"; Algorithms for the Diagnosis of MS; Imparting a Diagnosis of MS; 6. Complications and Comorbidities of Multiple Sclerosis; Loss of Bone Density (Osteopenia or Osteoporosis); Sleep Apnea and Other Altered Sleep Patterns; Mood Disturbances; Urinary Tract and Other Infections; Sexual Dysfunction; Skin Lesions.
- Joint DysfunctionObesity; 7. Relapses of Multiple Sclerosis and Their Treatment; What Constitutes a Relapse?; Conventional Relapse Treatments; Unconventional Relapse Treatments; Relapse Prevention; 8. Long-Term Disease-Modifying Therapies; Issues with Long-Term Immune-Modulating Therapies; Choosing a Disease-Modifying Therapy; Ensuring Treatment Adherence and Compliance; When Do I Initiate Treatment With Disease-Modifying Therapies?; Pregnancy, Breastfeeding, and Disease-Modifying Therapies; Beta-Interferons; Neutralizing Antibodies to Beta-Interferon; Glatiramer Acetate.
- Issues With Glatiramer AcetateFingolimod; Teriflunomide; Second-Line Disease-Modifying Therapies; Mitoxantrone; Natalizumab; Switching Disease-Modifying Therapies, or Defining the Insufficient Responder; When Should Long-Term Immune-Modulating Therapy Be Stopped?; Future Therapies; 9. Management of Multiple Sclerosis Symptoms; Fatigue; Depression; Pain; Spasticity; Weakness; Bladder, Bowel, and Sexual Dysfunction; Cognitive Impairment; Conclusion; 10. Complementary Therapies for Multiple Sclerosis; Nurses Certified in the Care of Persons with MS; Physical Therapy; Exercise Physiologists.
- Occupational TherapyPsychiatrists, Counselors, and Psychologists; Neuropsychologists; Orthotists; Neuro-Ophthalmologists; Urologists; Social Workers; Diet, Nutrition, and Food Supplements; 11. Gender Issues and Special Multiple Sclerosis Populations; Women; Menses; Disease-Modifying Therapies and Pregnancy; Pregnancy; Restarting Disease-Modifying Therapy and the Role of Breastfeeding; Men; Children of Parents with MS; Pediatric MS; 12. Resources; Websites; Websites for MS Specialty Certification; Patient Advocacy Organizations.